Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
Financing Cash Flow Over Time
Trending lower, below historical average.
Left:
||||
Cash from issuing/repaying debt and equity
Latest
$-1.49B
↓ 308% below average
Average (9y)
$-366.19M
Historical baseline
Range
High:$188.92M
Low:$-1.49B
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-1.49B | -165.9% |
| 2023 | $-562.20M | -730.4% |
| 2022 | $-67.70M | +95.4% |
| 2021 | $-1.48B | -192.5% |
| 2020 | $-505.28M | -498.6% |
| 2019 | $126.77M | +278.0% |
| 2018 | $-71.22M | -204.1% |
| 2017 | $68.40M | -48.7% |
| 2016 | $133.27M | -29.5% |
| 2015 | $188.92M | - |